More articles from Emerging Therapies: Drugs and Regimens

You have access
Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial
Serge A. Jabbour, Juan P. Frías, Azazuddin Ahmed, Elise Hardy, Jasmine Choi, C. David Sjöström, Cristian Guja

Diabetes Care Oct 2020, 43 (10) 2528-2536; DOI: 10.2337/dc19-1350
Open Access
Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C. Carr, Jason Mallory, Philip Home

Diabetes Care Oct 2020, 43 (10) 2509-2518; DOI: 10.2337/dc19-2316
You have access
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
Yuejuan Qin, John Adams, Carolina Solis-Herrera, Curtis Triplitt, Ralph DeFronzo, Eugenio Cersosimo

Diabetes Care Oct 2020, 43 (10) 2519-2527; DOI: 10.2337/dc19-1993
You have access
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes
Roselle A. Herring, Fariba Shojaee-Moradie, Robert Garesse, Mary Stevenage, Nicola Jackson, Barbara A. Fielding, Agampodi Mendis, Sigurd Johnsen, A. Margot Umpleby, Melanie Davies, David L. Russell-Jones

Diabetes Care Sep 2020, 43 (9) 2128-2136; DOI: 10.2337/dc19-2579
You have access
Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes
Daniel R. Quast, Nina Schenker, Björn A. Menge, Michael A. Nauck, Christoph Kapitza, Juris J. Meier

Diabetes Care Sep 2020, 43 (9) 2137-2145; DOI: 10.2337/dc20-0720
You have access
Effect of Afrezza on Glucose Dynamics During HCL Treatment
Alfonso Galderisi, Nathan Cohen, Peter Calhoun, Kristen Kraemer, Marc Breton, Stuart Weinzimer, Eda Cengiz

Diabetes Care Sep 2020, 43 (9) 2146-2152; DOI: 10.2337/dc20-0091
You have access
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
Christopher K. Rayner, Linda E. Watson, Liza K. Phillips, Kylie Lange, Michelle J. Bound, Jacqueline Grivell, Tongzhi Wu, Karen L. Jones, Michael Horowitz, Ele Ferrannini, Domenico Tricò, Silvia Frascerra, Andrea Mari, Andrea Natali

Diabetes Care Aug 2020, 43 (8) 1813-1821; DOI: 10.2337/dc20-0190
You have access
Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [¹⁸F]Fluorodeoxyglucose PET-MRI
Yasuko Morita, Munenobu Nogami, Kazuhiko Sakaguchi, Yuko Okada, Yushi Hirota, Kenji Sugawara, Yoshikazu Tamori, Feibi Zeng, Takamichi Murakami, Wataru Ogawa

Diabetes Care Aug 2020, 43 (8) 1796-1802; DOI: 10.2337/dc20-0093
Open Access
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
Vlado Perkovic, Robert Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Bernard Zinman, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Maximillian von Eynatten, Jyothis T. George, Odd Erik Johansen, Christoph Wanner

Diabetes Care Aug 2020, 43 (8) 1803-1812; DOI: 10.2337/dc20-0279
Open Access
Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
Thomas Danne, William V. Tamborlane, Oleg A. Malievsky, Denise R. Franco, Tomoyuki Kawamura, Marek Demissie, Elisabeth Niemoeller, Harmonie Goyeau, Marek Wardecki, Tadej Battelino

Diabetes Care Jul 2020, 43 (7) 1512-1519; DOI: 10.2337/dc19-1926

Main menu

User menu

Search

More articles from Emerging Therapies: Drugs and Regimens

Pages

Navigate

More Information

Other ADA Resources